PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663434
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1663434
Endoscopic Stricture Management Device Market size was valued at US$ 891.6 Million in 2024, expanding at a CAGR of 5.20% from 2025 to 2032.
Endoscopic stricture management devices are medical tools used to diagnose, treat, and manage gastrointestinal (GI) tract strictures. In the oesophagus, stomach, small intestine, or colon, among other areas of the digestive system, there are aberrant narrowings or constrictions known as strictures. There are a number of reasons for these strictures, including inflammation, scarring, tumours, and previous surgical procedures. In order to treat strictures, endoscopic techniques are performed, which provide less intrusive methods that circumvent the complications that come with open surgery. Common endoscopic stricture management tools include bougie dilators, stents, and balloon dilators. The endoscopic stricture management device market is growing as a result of the rise in gastrointestinal disorders and the use of cutting-edge technologies in endoscopic procedures. Endoscopic stricture management devices make it possible to diagnose and treat gastrointestinal tract strictures effectively. The global increase in the prevalence of chronic digestive disorders is driving market growth. Additionally, the industry's producers have a number of business prospects due to advancements in medical technology and investments in healthcare facilities.
Endoscopic Stricture Management Device Market- Market Dynamics
Rise in the incidence of gastrointestinal disorders
Gastrointestinal illnesses can result from a number of conditions that impact the gastrointestinal system, including cancer, inflammatory bowel disease, post-surgical scarring, and gastroesophageal reflux disease. Endoscopic stricture can be brought on by illnesses of the digestive system, including Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease (GERD). Stent replacement or dilatation with a gastrointestinal narrowing intervention device are two therapeutic options for treating these strictures. The rise in the prevalence of gastrointestinal disorders is, therefore, driving statistics on the market for endoscopic stricture management devices. Furthermore, equipment for treating precision endoscopic strictures is made to deliver precise, regulated, and efficient care. To help with the exact placement of the balloon inside the stricture, precision balloon dilators are fitted with marks or indicators. In order to promote a quicker recovery, surgeons and doctors prefer precise equipment during procedures. As a result, the market for endoscopic stricture management devices is expanding due to the rising need for precision medical equipment.
Endoscopic Stricture Management Device Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.20% over the forecast period (2025-2032)
Based on application segmentation, the oesophagal was predicted to show maximum market share in the year 2024
Based on end use segmentation, hospitals were the leading segment in 2024
On the basis of region, North America was the leading revenue generator in 2024
The Global Endoscopic Stricture Management Device Market is segmented on the basis of Application, Product, End Use, and Region.
On the basis of product, the market is segregated into Stents (Plastic stents, Metal stents, Biodegradable stents), Bougie dilators, Balloon dilators (Balloon inflation devices, Balloon dilator catheters), and Other products. In 2024, the market was dominated by the stents category. A stent is a hollow, flexible, self-expandable tube made of plastic or metal that is used to help clear any blockage in the gastrointestinal (GI) tract caused by a clog. Enteral stents are used as a surgical preparation tool or to enable the patient to continue eating. Additionally, the development of GI stents alleviates the symptoms of several GI tract-clogging illnesses. Thus, the usage of stents is growing due to the rise in GI disorders worldwide and the benefits they offer. This is fueling segment growth. Furthermore, the industry is expected to rise as a result of the technological developments in stents for improved results. For instance, Micro-Tech Endoscopy unveiled the first self-expanding tracheobronchial nitinol y-stent in February 2022. Patients with malignant tracheobronchial strictures can benefit from the Y-shaped tracheal Stent System's easy-to-use design and nitinol self-expanding construction. As a result, this development is anticipated to support the segment's expansion.
Based on end use, the market is divided into Hospitals, Ambulatory surgery centers (ASCs), and Others. In 2024, the hospitals category held a dominant market share attributed to the rise in gastrointestinal and oesophagal conditions that need endoscopic treatment. In addition to providing access to qualified medical experts and specialized treatment, hospitals are the main hubs for cutting-edge diagnostic and therapeutic methods. Endoscopic stricture management devices are becoming more and more in demand as hospitals adopt less intrusive procedures. Furthermore, the availability of cutting-edge equipment in hospital settings and improvements in endoscopic technology improve the effectiveness of stricture care, making hospitals a patient's first choice.
Endoscopic Stricture Management Device Market- Geographical Insights
In 2024, North America held a dominant position in the global market for Endoscopic Stricture Management Devices due to the rise in the prevalence of digestive disorders and the accessibility of cutting-edge medical facilities. Additionally, the rise in chronic illness prevalence brought on by dietary changes is driving the endoscopic stricture management device market expansion. For instance, about twenty million Americans have long-term digestive disorders that require 25% of all surgeries. In the US, digestive disorders are the third most expensive sickness overall. In the United States, approximately 14 million cases of acute digestive diseases-including some of the most prevalent acute infections and one-third of all malignancies-are treated annually.
However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The region's growing gastrointestinal and urological problems have raised demand for cutting-edge medical equipment, such as endoscopic stricture management systems. Greater accessibility to these technologies has also been made possible by the region's growing healthcare infrastructure, especially in developing nations like China, India, and Southeast Asia. Further driving market expansion are government programs to enhance healthcare services, growing healthcare costs, and more knowledge of minimally invasive procedures.
There are numerous products on the market, making the endoscopic stricture management device market as a whole competitive. The leading worldwide businesses make the majority of the stricture control devices. With greater resources for research and an improved distribution network, market leaders have solidified their place in the industry. Furthermore, as awareness of the stricture and procedures is growing, some minor firms are emerging in the market under study. Among the leading companies in the endoscopic stricture management device market are Boston Scientific Corporation, CONMED Corporation, Becton, Dickinson and Company, Merit Medical Systems, Steris plc (Diagmed Healthcare), and others. For instance, in October 2022, Medi-Globe GmbH declared its intention to open a new branch in Beijing as part of its expansion into China. The company aims to improve support for its clinical clients and trading partners in China as a key part of its worldwide expansion plan. It also seeks to provide the groundwork for developing strategic partnerships with forward-thinking Chinese medical technology companies.
Recent Development
December 2023: The GI Genius intelligent endoscopy module was introduced by Medtronic, a world leader in medical technology, services, and solutions, in collaboration with Cosmo Pharmaceuticals, a pioneer in the development of advanced intelligent medical devices. Through the use of artificial intelligence, they want to transform endoscopy and enhance patient outcomes.
June 2023: To strengthen their position in the dialysis and biopsy sectors, Merit Medical Systems, a world leader in the medical device sector, purchased AngioDynamics, a global supplier of cutting-edge medical equipment. The business purchased the biopsy system and catheter portfolio of AngioDynamics.